BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $45,980,000 | +1.9% | 543,663 | -3.0% | 0.64% | +0.9% |
Q4 2020 | $45,120,000 | -3.9% | 560,672 | -3.6% | 0.63% | -14.1% |
Q3 2020 | $46,930,000 | -17.1% | 581,673 | -11.3% | 0.74% | -15.0% |
Q2 2020 | $56,628,000 | -14.9% | 655,577 | -19.8% | 0.87% | -27.2% |
Q1 2020 | $66,519,000 | -7.4% | 817,285 | -4.7% | 1.19% | +26.2% |
Q4 2019 | $71,855,000 | +36.7% | 857,219 | +43.0% | 0.94% | +36.8% |
Q3 2019 | $52,568,000 | +0.9% | 599,467 | -5.5% | 0.69% | +3.3% |
Q2 2019 | $52,096,000 | +2.8% | 634,464 | +2.0% | 0.67% | -1.0% |
Q1 2019 | $50,695,000 | +27.4% | 622,065 | +3.2% | 0.68% | +15.0% |
Q4 2018 | $39,794,000 | -8.9% | 603,048 | +6.7% | 0.59% | +6.5% |
Q3 2018 | $43,661,000 | +1.9% | 565,050 | -2.4% | 0.55% | -13.8% |
Q2 2018 | $42,865,000 | +14.0% | 579,125 | +0.4% | 0.64% | +10.2% |
Q1 2018 | $37,613,000 | +4.5% | 576,987 | +3.9% | 0.58% | +4.9% |
Q4 2017 | $35,983,000 | -67.1% | 555,385 | -7.0% | 0.55% | -69.2% |
Q3 2017 | $109,461,000 | +79.6% | 597,163 | -40.5% | 1.80% | +70.4% |
Q2 2017 | $60,951,000 | +42.3% | 1,004,378 | +21.9% | 1.06% | +12.6% |
Q1 2017 | $42,823,000 | +13.2% | 823,872 | -3.1% | 0.94% | +14.8% |
Q4 2016 | $37,814,000 | +3.5% | 850,456 | -23.3% | 0.82% | -7.3% |
Q3 2015 | $36,518,000 | -52.9% | 1,108,253 | +0.5% | 0.88% | -50.3% |
Q2 2015 | $77,552,000 | -0.5% | 1,102,348 | -2.4% | 1.77% | -6.0% |
Q1 2015 | $77,907,000 | -7.6% | 1,129,679 | -1.2% | 1.88% | -6.9% |
Q4 2014 | $84,322,000 | +1.8% | 1,143,106 | -0.4% | 2.02% | -0.1% |
Q3 2014 | $82,838,000 | +18.3% | 1,148,243 | +21.4% | 2.03% | +12.9% |
Q1 2014 | $70,051,000 | – | 946,109 | – | 1.80% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |